Cyclopentenyl uracil, a non-cytotoxic inhibitor of uridine kinase, was
found to effectively block the salvage of circulating uridine by host
and tumor tissues in the intact mouse. Dose-response characteristics
of the inhibition were determined. Large doses (1 g/kg) of cyclopenten
yl uracil were required, and the effect of a single dose fell rapidly
over a 24-hr period. A sustained inhibition of uridine salvage of >64-
79% could be maintained by multiple doses of 1 g/kg given on an every
8-hr schedule. Mice given cyclopentenyl uracil (1 g/kg) every 8 hr for
5 days continued to gain weight and showed no signs of toxicity; howe
ver, the combination of cyclopentenyl uracil with a non-toxic dose of
N-(phosphonacetyl)-L-aspartic acid (PALA; 200 mg/kg daily for 5 days)
was lethal to mice, indicating that circulating uridine modifies the t
oxicity of agents that act on enzymes of the de novo pyrimidine pathwa
y. Although the duration of action and potency of cyclopentenyl uracil
are not ideal, this is the first demonstration of an effective inhibi
tion of uridine salvage in the intact mouse with a non-cytotoxic agent
. This makes possible the evaluation of concurrent inhibition of de no
vo and salvage routes to pyrimidine nucleotides as an approach to chem
otherapy.